Analyst firms · Raymond James · ZIOP

Raymond James ZIOP price target and rating history

ZIOPHARM Oncology Inc (ZIOP) · Health Care

Raymond James rates ZIOPHARM Oncology Inc (ZIOP) Market Perform with a $2 price target, as of its latest action on Nov 9, 2021. It has published 3 rating actions on ZIOP since August 2021, including 0 upgrades and 2 downgrades.

Current rating
Market Perform
Price target
$2
Median target, all firms
Too few
Actions on ZIOP
3

Raymond James price target on ZIOP

$3$2.50$220222023202420252026
Raymond James price target on ZIOP, each point a stated target, August 2021 to November 2021.

Every Raymond James rating on ZIOP

Questions about Raymond James and ZIOP

What is Raymond James's price target for ZIOP?
Raymond James's latest stated price target for ZIOPHARM Oncology Inc (ZIOP) is $2, from its action on Nov 9, 2021.
What is Raymond James's rating on ZIOP?
Raymond James rates ZIOP Market Perform, a neutral rating, as of Nov 9, 2021.
When did Raymond James last change its view on ZIOP?
On Nov 9, 2021, Raymond James cuts its price target to $2 from $3, keeps Market Perform.

All Raymond James ratingsZIOP news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.